Current Gastroenterology Reports

, Volume 1, Issue 6, pp 518–523

Therapy for H. pylori infection

  • Alan B. R. Thomson
Article

Abstract

The discovery that peptic upcers can be caused by gastroduodenal infection with Helicobacter pylori and cured by eradication of this bacterial presence has made a profound impact on ulcer management. This article reviews the principles behind such treatment and the regimens in current use, including proton pump inihibitor triple therapies and ranitidine bismuth citrate triple therapies.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Marshall BJ, Warren JR: Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984, vol 1:8390:1311–1314.PubMedCrossRefGoogle Scholar
  2. 2.
    Warren JR, Marshall B: Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983, 1:1273–1275.Google Scholar
  3. 3.
    Van Zanten SJO, Sherman PM: Helicobacter pylori infection as a cause of gastritis, duodenal ulcer, gastric cancer and non-ulcer dyspepsia: a systemic overview. Can Med Assoc J 1994, 150:177–185.Google Scholar
  4. 4.
    Graham DY, Adam E, Reddy GT: Seroepidemiology of Helicobacter pylori infection in India: comparison of developing and developed countries. Dig Dis Sci 1991, 36:1084–1088.PubMedCrossRefGoogle Scholar
  5. 5.
    Graham DY, Malaty HM, Evans DG, et al.: Epidemiology of H. pylori in an asymptomatic population in the United States: effect of age, race and socioeconomic status. Gastroenterology 1991,100:1495–1501.PubMedGoogle Scholar
  6. 6.
    Laine L, Hopkins RJ, Girardi LS: Has the impact of Helicobacter pylori therapy on ulcer recurrence in the United States been overstated? A meta-analysis of rigorously designed trials. Am J Gastroenterol 1998, 93:1409–1415. This meta-analysis showed that, in 20% of North American patients with duodenal ulcers not related to the use of NSAIDs, these ulcers are not apparently associated with H. pylori infection and do not heal with its eradication. These results indicate that non-H. pylori and non-NSAID ulcers may be more common than once thought.PubMedGoogle Scholar
  7. 7.
    Armstrong D, Hunt RH: Helicobacter pylori and dyspepsia: a conceptual approach. In Helicobacter pylori: Basic Mechanisms to Clinical Cure. Edited by Hunt RH, Tytgat GNJ. Lancaster: Kluwer Academic Publishers; 1996:324–339.Google Scholar
  8. 8.
    Armstrong D: Helicobacter pylori and dyspepsia. Scand J Gastroenterol 1996, 215 (suppl):38–47.Google Scholar
  9. 9.
    Van Zanten SJO, Sherman PM, Hunt RHH: Helicobacter pylori: new developments and treatments. Can Med Assoc J 1997, 156:1565–1574.Google Scholar
  10. 10.
    McColl K, Murray L, El-Omar E, et al.: Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia. N Engl J Med 1998, 339:1869–1874. Report from an important randomized, single-center, placebocontrolled study indicating a clear benefit in symptom relief to dyspeptic patients through treatment with omeprazole and antibiotics to eradicate infection.PubMedCrossRefGoogle Scholar
  11. 11.
    Blum AL, Talley NJ, O'Morain C, et al.: Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. N Engl J Med 1998, 339:1875–1881. Contrasting results from those of McColl et al. [10] from this carefully performed double-blinded, multicenter trial show that H. pylori eradication was not associated with treatment success.PubMedCrossRefGoogle Scholar
  12. 12.
    Malfertheiner P, Megraud F, O'Morain C: The European Helicobacter pylori Study Group (EHPSG): Current European concepts in the management of Helicobacter pylori infection: the Maastricht Consensus Report. Gut 1997, 41:8–13.CrossRefGoogle Scholar
  13. 13.
    Lam SK, Talley NJ: Helicobacter pylori consensus: report of the 1997 Asia Pacific Consensus conference on the management of Helicobacter pylori infection. J Gastroenterol Hepatol 1998, 13:1–12.PubMedGoogle Scholar
  14. 14.
    Hunt RH, Thomson ABR: Consensus Conference participants: Canadian Helicobacter pylori Consensus Conference. Can J Gastroenterol 1998, 12:31–41.PubMedGoogle Scholar
  15. 15.
    Report of the Digestive Health Initiative SM International Update Conference on Helicobacter pylori. Gastroenterology 1997, 113(suppl): S4–S8.Google Scholar
  16. 16.
    Parsonnet J, Harris RA, Cack HM, Owens DK: Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials. Lancet 1996, 348:150–154.PubMedCrossRefGoogle Scholar
  17. 17.
    Lind T, van Zanten SV, Unge P, et al.: Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: The MACH1 Study. Helicobacter 1996, 1:138–144.PubMedCrossRefGoogle Scholar
  18. 18.
    Van Zanten SJO, Bradette M, Farley A, et al.:. The DU-MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy. Aliment Pharmacol Ther 1999, 13:289–295. Results from this important Canadian randomized study of two omeprazole triple therapies indicates that the drugs are safe and that 1-week regimens of both combinations result in eradication, healing, and relapse prevention.PubMedCrossRefGoogle Scholar
  19. 19.
    Malfertheiner P, Bayerdorffer E, Diete U, et al.: The GU-MACH study: the effect of 1-week omeprazole triple therapy on Helicobacter pylori infection in patients with gastric ulcer. Aliment Pharmacol Ther 1999, 13:703–712. This reported international study involved the same regimen of omeprazole triple therapy as that for Van Zanten et al. [18]. Likewise, regimens were proven safe and effective, with infrequent ulcer relapse.PubMedCrossRefGoogle Scholar
  20. 20.
    Huang J-Q, Hunt RH: The importance of clarithromycin dose in the management of Helicobacter pylori infection: a meta-analysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxicillin or metronidazole. Aliment Pharmacol Ther 1999, 13:719–729. A major meta-analysis of 1-week twice-daily triple therapies consisting of a proton pump inhibitor, clarithromycin, and amoxicillin or metronidazole. A higher dose of clarithromycin (500 mg vs 250 mg) appears to give superior eradication rates.PubMedCrossRefGoogle Scholar
  21. 21.
    Miwa H, Ohkura R, Murai T, et al.: Impact of rabeprazole, a new proton pump inhibitor, in triple therapy for Helicobacter pylori infection: comparison with omeprazole and lansoprazole. Aliment Pharmacol Ther 1999, 13:741–746. This Japanese study of 221 duodenal ulcer patients showed similar results with three different PPIs (omeprazole, lansoprazole, and rabeprazole).PubMedCrossRefGoogle Scholar
  22. 22.
    Ducons JA, Santolaria S, Guirao et al.: Impact of clarithromycin resistance on the effectiveness of a regimen for Helicobacter pylori: a prospective study of 1-week lansoprazole, amoxicillin and clarithromycin in active peptic ulcer. Aliment Pharmacol Ther 1999, 13:775–780. Clarithromycin resistance reduces the effectiveness of combine therapy when administered along with lansoprazole, 30 mg, an amoxicillin, 1 g, from 83% to 20%, according to this report. As clarithromycin resistance becomes more prevalent, this will become an important clinical problem.PubMedCrossRefGoogle Scholar
  23. 23.
    Sung JJY, Leung WK, Ling TKW, et al.: One-week use of ranitidine bismuth citrate, amoxicillin and clarithromycin for the treatment of Helicobacter pylori-related duodenal ulcer. Aliment Pharmacol Ther 1998, 12:725–730. This Chinese study showed signficant ITT eradication rates with a combined treatment regimen.PubMedCrossRefGoogle Scholar
  24. 24.
    Spadaccini A, Fanis C, Sciampa G, et al.: Triple regimens using lansoprazole or ranitidine bismuth citrate for Helicobacter pylori eradication. Aliment Pharmacol Ther 1998, 12:997–1001.PubMedCrossRefGoogle Scholar
  25. 25.
    Hawkey CJ, Karrasch JA, Szczepanski L, et al.: Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. N Engl J Med 1998, 338:727–734. Results from this study indicate that omeprazole was more effective in healing of gastric and duodenal ulcers than misoprostol, whereas misoprostol was more effective in patients with erosions alone.PubMedCrossRefGoogle Scholar
  26. 26.
    Hawkey CJ, Tulassay Z, Szczepanski L, et al.: Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Lancet 1998, 352:1016–1021. NSAID gastric ulcers may heal faster in the presence of an H. pylori infection, based on findings in this report.PubMedCrossRefGoogle Scholar
  27. 27.
    Chan FKL, Sung JJY, Chung SCS et al.: Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers. Lancet 1997, 350:975–979. These authors indicate that H. pylori infection may heighten risk of ulcer development in ulcer-naïve patients given NSAIDs.PubMedCrossRefGoogle Scholar
  28. 28.
    Yeomans ND, Tulassay Z, Laszlo J, et al.: A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal anti-inflammatory drugs. N Engl J Med 1998, 338:719–726. In the maintenance phase of this reported study, a higher proportion of H. pylori patients remained in remission.PubMedCrossRefGoogle Scholar
  29. 29.
    Holtmann G, Cain C, Malfertheiner P: Gastric Heliobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole. Gastroenterology 1999, 117:11–16. This large study showed high overall healing rates of reflux esophagitis and relief of symptoms. H. pylori-positive patients also showed a high rate of healing and symptom relief.PubMedCrossRefGoogle Scholar

Copyright information

© Current Science Inc 1999

Authors and Affiliations

  • Alan B. R. Thomson
    • 1
  1. 1.Nutrition and Metabolism Research Group, Division of Gastroenterology519 Newton Research Building, University of AlbertaEdmontonCanada

Personalised recommendations